Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kaiser

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Cancer Immunology, Immunotherapy : CII|June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinomaAurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Interleukin-2-dependent mechanisms of tolerance and immunity in vivoPaul A Antony, Chrystal M Paulos, Mojgan Ahmadzadeh, et al.
Human Gene Therapy|May 1, 2008
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2Bianca Heemskerk, Ke Liu, Mark E Dudley, et al.
Human Gene Therapy|August 30, 2017
Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical UseDominik Lock, Nadine Mockel-Tenbrinck, Katharina Drechsel, et al.
The Journal of Clinical Investigation|July 28, 2007
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signalingChrystal M Paulos, Claudia Wrzesinski, Andrew Kaiser, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2021
Automated generation of gene-edited CAR T cells at clinical scaleJamal Alzubi, Dominik Lock, Manuel Rhiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2019
Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® PlatformKrasimira Aleksandrova, Jana Leise, Christoph Priesner, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Automated, scaled, transposon-based production of CAR T cellsDominik Lock, Razieh Monjezi, Caroline Brandes, et al.
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinomaAurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Interleukin-2-dependent mechanisms of tolerance and immunity in vivoPaul A Antony, Chrystal M Paulos, Mojgan Ahmadzadeh, et al.
Human Gene Therapy|May 1, 2008
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2Bianca Heemskerk, Ke Liu, Mark E Dudley, et al.
Human Gene Therapy|August 30, 2017
Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical UseDominik Lock, Nadine Mockel-Tenbrinck, Katharina Drechsel, et al.
The Journal of Clinical Investigation|July 28, 2007
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signalingChrystal M Paulos, Claudia Wrzesinski, Andrew Kaiser, et al.
Molecular Therapy. Methods & Clinical Development|February 12, 2021
Automated generation of gene-edited CAR T cells at clinical scaleJamal Alzubi, Dominik Lock, Manuel Rhiel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 28, 2019
Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® PlatformKrasimira Aleksandrova, Jana Leise, Christoph Priesner, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Automated, scaled, transposon-based production of CAR T cellsDominik Lock, Razieh Monjezi, Caroline Brandes, et al.
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
Pageof 4